Original articleClinical endoscopyAwareness of guidelines and trends in the management of suspected pancreatic cystic neoplasms: survey results among general gastroenterologists and EUS specialists
Section snippets
Study participants
This study was approved by the Johns Hopkins University School of Medicine Institutional Review Board. An Internet, Web-based survey was designed to address the different practice habits of 2 groups of physicians: (1) a general group of gastroenterologists and GI surgeons (general group) and (2) a group of EUS specialists (EUS group). General group members were contacted by e-mail on 2 occasions, between March and May 2006, alerting them to a Web site link that contained the online
Section 1: respondent demographics
Questionnaire response rates were tabulated for both groups of participants. In the general group of GI specialists, 8.8% of the people who received the e-mail solicitation completed the survey (220/2500). In the EUS group, 9.7% of EUS-SIG members responded (42/431).
The characteristics of both groups of respondents are shown in Table 1. In the general group, 28.2% of respondents were GI surgeons compared with 4.8% in the EUS group (P < .001). Both groups were predominantly men (P = .59) and
Discussion
Noninflammatory pancreatic cysts are increasingly discovered with the expanding use of modern-day CT scanners and MRI machines.18, 19 Often, patients are incidentally found to have a small cystic lesion in their pancreas on a CT done for the evaluation of renal calculi or another benign disease. After discussion with their primary care physician, they are frequently referred to a gastroenterologist or a GI surgeon for guidance regarding the management of such lesions. The specialist is then
Acknowledgments
We thank James Harper and the Internet technology team of Olympus America for assistance. We appreciate their support in designing the survey Web site and for maintaining the data collection.
References (20)
- et al.
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas
Pancreatology
(2006) - et al.
Surgical management of intraductal papillary mucinous tumor of the pancreas
Surgery
(2002) - et al.
Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas
J Gastrointest Surg
(2003) - et al.
Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer
Clin Gastroenterol Hepatol
(2004) - et al.
Endoscopic transmural drainage of pancreatic pseudocysts: results of a national and international survey of ASGE members
Gastrointest Endosc
(2006) - et al.
ASGE guideline: the role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas
Gastrointest Endosc
(2005) - et al.
Analysis of small cystic lesions of the pancreas
Int J Pancreatol
(1995) - et al.
Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients
Arch Surg
(2003) - et al.
Cystic lesions of the pancreas: introduction
Semin Diagn Pathol
(2000) - et al.
Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management
Arch Surg
(1999)
Cited by (21)
Endoscopic Ultrasound Imaging for Diagnosing and Treating Pancreatic Cysts
2017, Gastrointestinal Endoscopy Clinics of North AmericaCitation Excerpt :However, factors associated with progression of SB-IPMN lesions remain to be fully elucidated, resulting in significant heterogeneity in the management styles of these lesions. This issue is further complicated by the paucity of long-term follow-up data beyond 5 years, and concerns among clinicians about adherence to the consensus guidelines or the lack of awareness of the guidelines.141–143 There are limited data on the nonoperative management of small MCNs, but recent systematic review indicates that only 0.03% of resected lesions less than 4 cm in size harbored invasive adenocarcinoma.144
Questionnaires used to assess barriers of clinical guideline use among physicians are not comprehensive, reliable, or valid: a scoping review
2017, Journal of Clinical EpidemiologyCitation Excerpt :Ultimately, 178 studies were eligible for analysis (Fig. 1, PRISMA diagram). Data extracted from included studies are available in Additional File 2 at www.jclinepi.com [17–50] [51–90] [91–128] [129–163] [164–194]. Studies were published from 2005 to 2015.
Follow-up of asymptomatic pancreatic cysts in clinical practice: A vignette questionnaire
2016, PancreatologyCitation Excerpt :The majority of EUS specialists evaluated small PCN with EUS instead of conventional US or HR-CT. This finding is in agreement with a study amongst GE and EUS specialists in the US [18]. It seems that EUS specialists tend to rely on their own judgment and more appreciate the benefits of EUS, such as the ability to detect malignant features and to perform FNA.
Get Ready to Meet the Growing Demand From Patients With Pancreatic Cysts
2016, Clinical Gastroenterology and HepatologyDiagnosis and Treatment of Cystic Pancreatic Tumors
2011, Clinical Gastroenterology and HepatologyCitation Excerpt :The factors involved in the progression of SB-IPMN lesions remain to be fully understood. This uncertainty could be partially related to the absence of long-term follow-up data, or concerns among clinicians about adherence to the consensus guidelines or the lack of awareness of the guidelines.125–127 There are limited data on the nonsurgical management of small MCNs in asymptomatic patients.
DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. This study was conducted in collaboration with Olympus America.
If you want to chat with an author of this article, you may contact him at [email protected].